Page 4 - க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Welcome To IANS Live - BUSINESS - Glenmark launches nasal spray for allergic rhinitis in India


Photo Credit: IANS
IANSLive
Chennai, May 3 (IANS) Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 03-May-2021 ....

Tamil Nadu , Glenmark Pharmaceuticals Limited On , News Service , India Private , Glenmark Pharmaceuticals Limited , All Rights , தமிழ் நாடு , செய்தி சேவை , இந்தியா ப்ரைவேட் , க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை , அனைத்தும் உரிமைகள் ,

Glenmark launches nasal spray in India for treating allergic rhinitis


Glenmark launches nasal spray in India for treating allergic rhinitis
Glenmark launches nasal spray in India for treating allergic rhinitis
03 May 2021 | News
Glenmark becomes the first company in the world to launch Ryaltris®-AZ as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg
image credit- shutterstock
Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. ....

Alok Malik , Group Vice , Glenmark Pharmaceuticals , Glenmark Pharmaceuticals Limited , Group Vice President , Business Head , India Formulations , அலோக் மாலிக் , குழு துணை , க்ளேண்மர்க் மருந்துகள் , க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை , குழு துணை ப்ரெஸிடெஂட் , வணிக தலை , இந்தியா சூத்திரங்கள் ,

Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India


Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India.
Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. This will provide patients a far more convenient, cost-effective treatment option in the country.
Glenmark is the first company in the world to launch Ryaltris®-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg. ....

Glenmark Ryaltris , Alok Malik , Group Vice , Glenmark Pharmaceuticals , Glenmark Pharmaceuticals Limited , Group Vice President , Business Head , India Formulations , Allergic Rhinitis , Intranasal Corticosteroid , Intranasal Antihistamine , Severe Allergic , Alok Malik , Allergic Rhinitis , அலோக் மாலிக் , குழு துணை , க்ளேண்மர்க் மருந்துகள் , க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை , குழு துணை ப்ரெஸிடெஂட் , வணிக தலை , இந்தியா சூத்திரங்கள் , கடுமையானது ஒவ்வாமை ,